Press Release | ImmuneMed

Press Release

Total 7, 1/2 Page

게시판 리스트
No. Subject Writer Date of Preparation Views
7 [Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
  • ImmuneMed
  • 2021-01-08
ImmuneMed 2021-01-08 556
6 COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
  • ImmuneMed
  • 2020-12-21
ImmuneMed 2020-12-21 493
5 Obtaining Approval Letter of Investigational New Drug (IND) for COVID-19 Phase 2
Study in Republic of Korea on 7th December, 2020
  • ImmuneMed
  • 2020-12-07
ImmuneMed 2020-12-07 498
4 COVID-19 Phase 2 Clinical Study Approval (Indonesia), December 1st, 2020
  • ImmuneMed
  • 2020-12-01
ImmuneMed 2020-12-01 2835
3 COVID-19 Phase 2 Clinical Study Approval (Russia), October 15th, 2020
  • ImmuneMed
  • 2020-11-10
ImmuneMed 2020-11-10 2944
2 [Press Release] ImmuneMed’s ‘hzVSF,’ A New Hope for COVID-19 Pneumonia Patients
  • ImmuneMed
  • 2020-04-01
ImmuneMed 2020-04-01 2219